Shopping Cart 0
Cart Subtotal
USD 0

3-D Matrix Ltd (7777) - Product Pipeline Analysis, 2018 Update

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 750

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 1500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 2250
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates across the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company 3-D Matrix Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

3-D Matrix Ltd Company Overview 5

3-D Matrix Ltd Company Snapshot 5

3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

3-D Matrix Ltd-Pipeline Analysis Overview 8

Business Description 8

3-D Matrix Ltd-Key Facts 8

3-D Matrix Ltd-Major Products and Services 9

3-D Matrix Ltd Pipeline Products by Development Stage 10

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12

3-D Matrix Ltd Pipeline Products Overview 13

PuraMatrix Bone Void Filler 13

PuraMatrix Bone Void Filler Product Overview 13

PuraSINUS Gel 14

PuraSINUS Gel Product Overview 14

PuraStat Hemostat 15

PuraStat Hemostat Product Overview 15

PuraStat Hemostat Clinical Trial 16

TDM-511 17

TDM-511 Product Overview 17

TDM-623 18

TDM-623 Product Overview 18

TDM-641 19

TDM-641 Product Overview 19

TDM-651 20

TDM-651 Product Overview 20

3-D Matrix Ltd-Key Competitors 21

3-D Matrix Ltd-Key Employees 22

3-D Matrix Ltd-Key Employee Biographies 23

3-D Matrix Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

3-D Matrix Ltd, Recent Developments 25

May 10, 2018: Partnership Agreement concluded with DEMEDIC regarding sales and marketing of absorbable local hemostat PuraStat in Argentina 25

Apr 28, 2016: Partnership Agreement concluded with Kaplan regarding sales and marketing of absorbable local hemostat PuraStat in Chile 25

Apr 05, 2016: Patent Granted for Cardiac Tissue Regeneration with Self-Assembling Peptide Technology in Japan 25

Feb 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Mexico 26

Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors 26

Jan 25, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Thailand 27

Jan 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Australia 27

Dec 28, 2015: Partnership Agreement concluded with Transmedic regarding sales and marketing of PuraStat in Singapore, Malaysia and Brunei 27

Nov 04, 2015: Absorbable Hemostat TDM-621 Product Registration Obtained in Brazil 28

Oct 05, 2015: Partnership Agreement concluded with Maquet Australia regarding sales and marketing of absorbable local hemostat PuraStatin Australia 28

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

3-D Matrix Ltd Pipeline Products by Equipment Type 6

3-D Matrix Ltd Pipeline Products by Development Stage 10

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12


List Of Table

List of Tables

3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

3-D Matrix Ltd Pipeline Products by Equipment Type 6

3-D Matrix Ltd Pipeline Products by Indication 7

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 7

3-D Matrix Ltd, Key Facts 8

3-D Matrix Ltd, Major Products and Services 9

3-D Matrix Ltd Number of Pipeline Products by Development Stage 10

3-D Matrix Ltd Pipeline Products Summary by Development Stage 11

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12

3-D Matrix Ltd Ongoing Clinical Trials Summary 12

PuraMatrix Bone Void Filler-Product Status 13

PuraMatrix Bone Void Filler-Product Description 13

PuraSINUS Gel-Product Status 14

PuraSINUS Gel-Product Description 14

PuraStat Hemostat-Product Status 15

PuraStat Hemostat-Product Description 15

PuraStat Hemostat-A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 16

TDM-511-Product Status 17

TDM-511-Product Description 17

TDM-623-Product Status 18

TDM-623-Product Description 18

TDM-641-Product Status 19

TDM-641-Product Description 19

TDM-651-Product Status 20

TDM-651-Product Description 20

3-D Matrix Ltd, Key Employees 22

3-D Matrix Ltd, Key Employee Biographies 23

3-D Matrix Ltd, Subsidiaries 24

Glossary 31

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

3-D Matrix Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

PharmaDesign Inc

Kaketsuken

CellSeed Inc

Capital Genomix, Inc

Aushon BioSystems Inc

Summary

3-D Matrix Ltd (3-D Matrix) is a regenerative medicine company that focuses at commercializing its self-assembling peptide technology. It develops medical products by applying this technology under a license granted by Massachusetts Institute of Technology (MIT). The technology finds applications in the field of surgical and medical regenerative medicine, cell therapy and drug discovery. 3-D Matrix's lead product, PuraMatrix caters to periodontal bone regeneration. The company has several collaborative agreements with academic research institutions, enterprises and medical institutions. The company operates across the US, France, the Netherlands, China and Singapore. 3-D Matrix is headquartered in Chiyoda-ku, Tokyo, Japan.

This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company 3-D Matrix Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

3-D Matrix Ltd Company Overview 5

3-D Matrix Ltd Company Snapshot 5

3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

3-D Matrix Ltd-Pipeline Analysis Overview 8

Business Description 8

3-D Matrix Ltd-Key Facts 8

3-D Matrix Ltd-Major Products and Services 9

3-D Matrix Ltd Pipeline Products by Development Stage 10

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12

3-D Matrix Ltd Pipeline Products Overview 13

PuraMatrix Bone Void Filler 13

PuraMatrix Bone Void Filler Product Overview 13

PuraSINUS Gel 14

PuraSINUS Gel Product Overview 14

PuraStat Hemostat 15

PuraStat Hemostat Product Overview 15

PuraStat Hemostat Clinical Trial 16

TDM-511 17

TDM-511 Product Overview 17

TDM-623 18

TDM-623 Product Overview 18

TDM-641 19

TDM-641 Product Overview 19

TDM-651 20

TDM-651 Product Overview 20

3-D Matrix Ltd-Key Competitors 21

3-D Matrix Ltd-Key Employees 22

3-D Matrix Ltd-Key Employee Biographies 23

3-D Matrix Ltd-Locations And Subsidiaries 24

Head Office 24

Other Locations & Subsidiaries 24

Recent Developments 25

3-D Matrix Ltd, Recent Developments 25

May 10, 2018: Partnership Agreement concluded with DEMEDIC regarding sales and marketing of absorbable local hemostat PuraStat in Argentina 25

Apr 28, 2016: Partnership Agreement concluded with Kaplan regarding sales and marketing of absorbable local hemostat PuraStat in Chile 25

Apr 05, 2016: Patent Granted for Cardiac Tissue Regeneration with Self-Assembling Peptide Technology in Japan 25

Feb 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Mexico 26

Feb 15, 2016: 3-D Matrix: Announcement of Change of Representative Directors 26

Jan 25, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Thailand 27

Jan 22, 2016: Absorbable Hemostat PuraStat Product Registration Obtained in Australia 27

Dec 28, 2015: Partnership Agreement concluded with Transmedic regarding sales and marketing of PuraStat in Singapore, Malaysia and Brunei 27

Nov 04, 2015: Absorbable Hemostat TDM-621 Product Registration Obtained in Brazil 28

Oct 05, 2015: Partnership Agreement concluded with Maquet Australia regarding sales and marketing of absorbable local hemostat PuraStatin Australia 28

Appendix 29

Methodology 29

About GlobalData 32

Contact Us 32

Disclaimer 32


List Of Figure

List of Figures

3-D Matrix Ltd Pipeline Products by Equipment Type 6

3-D Matrix Ltd Pipeline Products by Development Stage 10

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12


List Of Table

List of Tables

3-D Matrix Ltd Pipeline Products and Ongoing Clinical Trials Overview 5

3-D Matrix Ltd Pipeline Products by Equipment Type 6

3-D Matrix Ltd Pipeline Products by Indication 7

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 7

3-D Matrix Ltd, Key Facts 8

3-D Matrix Ltd, Major Products and Services 9

3-D Matrix Ltd Number of Pipeline Products by Development Stage 10

3-D Matrix Ltd Pipeline Products Summary by Development Stage 11

3-D Matrix Ltd Ongoing Clinical Trials by Trial Status 12

3-D Matrix Ltd Ongoing Clinical Trials Summary 12

PuraMatrix Bone Void Filler-Product Status 13

PuraMatrix Bone Void Filler-Product Description 13

PuraSINUS Gel-Product Status 14

PuraSINUS Gel-Product Description 14

PuraStat Hemostat-Product Status 15

PuraStat Hemostat-Product Description 15

PuraStat Hemostat-A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 16

TDM-511-Product Status 17

TDM-511-Product Description 17

TDM-623-Product Status 18

TDM-623-Product Description 18

TDM-641-Product Status 19

TDM-641-Product Description 19

TDM-651-Product Status 20

TDM-651-Product Description 20

3-D Matrix Ltd, Key Employees 22

3-D Matrix Ltd, Key Employee Biographies 23

3-D Matrix Ltd, Subsidiaries 24

Glossary 31

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products

3-D Matrix Ltd, Product, Pipeline, Product Pipeline, Key Pipeline, Products by Equipment Type, Equipment Type, Therapy Area, Products by Therapy Area, Development Stage, Products by Development Stage, Milestone, Products by Milestone, Major Products, Brands, No of Products, Device Class, Market, Territory, Product Name, Therapy Name, Trial Name, Trial, Indication, Summary, Event Type, Clinical Trial, MileStone, Product Status, Product Description, Description, Patent, Patent Details, Competitors, Key Employees, Subsidiaries, Locations, News, Events, Developments, medical devices, business description, company facts, trial phase, approval, estimated, technology, product patent details, phase, trial status, trial objective, trial design, trial site, business strategies, trends, pipeline and technology, sales strategies


Companies

PharmaDesign Inc

Kaketsuken

CellSeed Inc

Capital Genomix, Inc

Aushon BioSystems Inc